C18H17NO5
327.3 g/mol
APIWarning
Tranilast
CAS53902-12-8
Category
API
Compound Class
Organic Acid
Primary Use
Pharmaceutical Raw Material
Tranilast is an antiallergic active pharmaceutical ingredient primarily used in pharmaceutical manufacturing. It was first approved in Japan and South Korea for bronchial asthma, with additional indications for keloid and hypertrophic scars added later.
antiallergic active pharmaceutical ingredientcompound for bronchial asthma manufacturingcompound for keloid and hypertrophic scar manufacturing
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 53902-12-8
Related Compounds
ReferenceSame Category
7-amino-3-chloro-3-cephem-4-carboxylic acid
CAS53994-69-7
pharmaceutical raw material
ReferenceSame Category
Cefaclor
CAS53994-73-3
pharmaceutical raw material
ReferenceSame Category
(−)-nicotine
CAS54-11-5
pharmaceutical raw material
ReferenceSame Category
Sodium salicylate
CAS54-21-7
pharmaceutical raw material
Referencesame scaffold
(E)-N-(3-Methoxyphenyl)-3-phenyl-2-propenamide
CAS127033-74-3
pharmaceutical intermediate
Safety Reference
Warning
H302Harmful if swallowed
Identifiers
IUPAC Name
2-[[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino]benzoic acid
InChIKey
NZHGWWWHIYHZNX-CSKARUKUSA-N
SMILES
COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC
Synonyms (37)
- D27
- Tranilast (JP18/USAN/INN)
- Tranilastum [INN-Latin]
- MK 341;SB 252218
- N-5'
- Rizaben
- Rizaben (TN)
- TRANILAST [MART.]
- Tranilast (SB 252218)
- Tranilast (trans-)
- Tranilast - Bio-X trade mark
- Tranilast Impurity 31
- Tranilastum
- Tranpro
- tranilast
- trans-Tranilast